Press Releases
January 12, 2026
MYTSV.COM Report Uncovers Stark U.S. Lifespan Paradox: World’s Wealthiest Nation Ranks Just 48th in Global Longevity
Neutral
EIN Presswire
January 12, 2026
HII Expands European Unmanned Operations with New Facility in Portchester, UK
Indeterminate
GlobeNewswire, Inc.
January 12, 2026
Game, Set, Match! Adelaide International starts today
Gov't Institution
Premier of South Australia
Owner: Australian Government
January 12, 2026
Village Farms International Advances New Product Innovation in the Dutch Market
Indeterminate
GlobeNewswire, Inc.
January 9, 2026
EFM Global Expanding Global Hotel Logistics with Appointment of Susannah Eustace as Account Director
Indeterminate
GlobeNewswire, Inc.
January 12, 2026
Pool Corporation Announces the Retirement of Kenneth G. St. Romain and the Appointment of John B. Watwood
Indeterminate
GlobeNewswire, Inc.
January 12, 2026
Elevra Lithium Announces Accelerated NAL Expansion
Indeterminate
GlobeNewswire, Inc.
January 5, 2026
Australia calls for diplomacy after US military operation in Venezuela
Indeterminate
MENAFN
Owner: Sawsan Dababneh & Ramzi AbdelJaber
January 12, 2026
Hangar 1 Publishing Releases Paranormal Apocalypse: New Book Uncovers Hidden Psychology Behind Humanity's End-Times Obsession
Indeterminate
GlobeNewswire, Inc.
January 8, 2026
'BANOVICH' Sells Out Deluxe Edition as a Decades-Long Body of Work Finds Global Resonance
Neutral
EIN Presswire
January 8, 2026
Under Pressure: Global CEO Pay Tectonics
Indeterminate
The Harvard Law School Forum on Corporate Governance
Owner: Harvard University
January 12, 2026
Catalina Resources Ltd (CTN.AX) dds Copper Exposure and Additional District-Scale Gold
Indeterminate
ABN Newswire
Owner: ABN Newswire
January 8, 2026
Tisento Therapeutics Completes Enrollment in PRIZM, a Global Phase 2b Study of Zagociguat for the Treatment of MELAS
Indeterminate
GlobeNewswire, Inc.
January 8, 2026
VivoPower Appoints Rachel Pether, Sovereign Wealth Fund Expert, to Global Advisory Council
Indeterminate
GlobeNewswire, Inc.
January 8, 2026
Nxera Pharma Licenses Japan and Select Asia-Pacific Rights to Vamorolone for Duchenne Muscular Dystrophy from Santhera Pharmaceuticals
Indeterminate
GlobeNewswire, Inc.